Product category:
Cleaning products
News Release from: GX Laboratories | Subject: GX+ with G-cide
Edited by the Laboratorytalk Editorial
Team on 29 December 2005
New disinfectant is 'revolutionary'
The G-cide complex has eliminated many of the safety issues of glutaraldehyde such as skin irritation, corrosion, sensitisation and potential respiratory problems
A 'revolutionary' new disinfectant being launched onto the worldwide market will have far reaching benefits across a number of industries, says its maker GX+ with G-cide contains the G-cide complex that allows glutaraldehyde to be used in a safer and more environmentally friendly way while enhancing its efficacy
This article was originally published on Laboratorytalk on 8 Apr 2004 at 8.00am (UK)
Related stories
Quantitated PCR control DNA for H pylori
Detection of H pylori by PCR assay has a sensitivity of up to 93%, with a specificity of 100% when compared to microbiologic culture and histologic examination of biopsy tissues
Quantitated PCR control DNA for polyomaviruses
Both JCV and BKV infections are transmitted from human to human (probably through the respiratory system), establish viremia, settle in the kidneys and remain latent in the host
GX+ with G-cide is set to revolutionise infection control, says GX Laboratories.
GX+ products contain the active ingredient G-cide (Inci name Glutaral C11-C15 Pareth 9) a new complex which is able to kill 99.9% of bacteria, viruses, fungi and spores in a much shorter time and similar concentrations than existing products.
G-cide is currently unrivalled in efficacy and safety by existing products of a similar type, says GX.
Further reading
Quantitated PCR control DNA for SV 40
Simian virus 40 is suspected to be a carcinogen, and is estimated to infect up to 30 million people in the USA as the result of contaminated polio vaccine used in the 1950s and 60s
Reagent kits optimised for array platform
These reagents offer a complete, standardised sample preparation system that is easier to use and will help customers produce more robust and consistent array results
The award-winning G-cide complex was created by South African scientist Toni Martin.
Toni Martin used the chemical glutaraldehyde and stabilised it by complexing it with a large molecular non-ionic surfactant.
The G-cide complex has eliminated many of the safety issues of glutaraldehyde such as skin irritation, corrosion, sensitisation and potential respiratory problems.
Glutaraldehyde at near neutral pH is only stable for a limited amount of time (14-28 days), whereas the G-cide complex is near neutral pH and can be safely stored for at least 12 months without reducing its efficacy.
GX laboratories has also established a strategic alliance with Dow Biocides for the exclusive supply of the highest quality glutaraldehyde from the world's leading supplier.
G-cide based products have positive implications for the agricultural and livestock sectors, helping prevent the spread of contact transmitted diseases such as foot and mouth and avian influenza.
The broad kill spectrum of GX+ with G-cide is also beneficial to the food industry, for transport as well as having the potential to seriously reduce a majority of hospital acquired infections.
The first range of GX+ products to become available will be a range of hand sanitisers, for use by medical staff.
The antimicrobial hand sanitiser, hand soap and moisturising creams are water based and, unlike existing products, are non-irritant and will not dry out the skin.
Hospital staff can use them frequently throughout the day without encountering the painful skin problems which have left many doctors and nurses understandably reluctant to sanitise their hands between patients.
The quick drying and non-greasy GX+ hand product range is also effective against the most serious pathogens and as a contact disinfectant, has a residual killing power that will help stop the transition of infection from patient to patient.
• GX Laboratories: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

